Clinic
Planned Parenthood League of Massachusetts, INC.
Planned Parenthood League of Massachusetts, INC. was paid $12.83M by Medicaid between Jan 2018 and Dec 2024, across 55 billing codes. Its largest line is J7307, Etonogestrel (contraceptive) implant system, including implant and supplies — 16% of everything it billed.
33Billing provider infoPLANNED PARENTHOOD LEAGUE OF MASSACHUSETTS, INC.
BOSTON, MA 02215
BOSTON, MA 02215
33aNPI1821095779assigned 07/07/2005
33bProvider typeAmbulatory Family Planning Facility
28Total paid$12.83M
24GClaims260,383
24DCodes billed55
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 41,752 | $1.84M | |
| 2019 | 39,105 | $1.79M | |
| 2020 | 26,780 | $1.40M | |
| 2021 | 45,336 | $2.16M | |
| 2022 | 40,102 | $1.90M | |
| 2023 | 36,676 | $1.99M | |
| 2024incomplete | 30,632 | $1.75M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 16% | 3,759 | 3,727 | $2.08M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 8.9% | 38,065 | 33,881 | $1.14M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 8.5% | 36,262 | 33,315 | $1.10M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.0% | 14,737 | 14,091 | $1.02M |
| J7297 | Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg | 6.9% | 2,180 | 2,156 | $883K |
| J7300 | Intrauterine copper contraceptive (paragard) | 4.7% | 1,295 | 1,273 | $604K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.7% | 10,197 | 9,852 | $478K |
| 58300 | 3.5% | 4,349 | 4,218 | $446K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 3.4% | 9,061 | 9,002 | $441K |
| 11981 | 3.4% | 3,224 | 3,192 | $431K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 3.2% | 5,667 | 5,599 | $411K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.1% | 3,911 | 3,785 | $401K |
43 more codes
| 99203 | Doctor's office visit, new patient (routine) | 3.0% | 3,544 | $381K |
| 11982 | 2.2% | 2,285 | $277K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.9% | 8,022 | $240K |
| 99152 | 1.7% | 3,613 | $223K | |
| 58301 | 1.6% | 2,100 | $199K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.5% | 10,249 | $187K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 1.3% | 2,596 | $168K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.2% | 1,593 | $156K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.2% | 920 | $148K |
| 87481 | 1.1% | 5,054 | $147K | |
| 81025 | 1.1% | 18,891 | $136K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1.1% | 2,202 | $136K |
| J7296 | Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg | <1% | 237 | $124K |
| 90651 | <1% | 654 | $120K | |
| 86703 | <1% | 8,956 | $101K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 3,336 | $98K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 152 | $90K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 995 | $75K |
| 87480 | <1% | 3,206 | $64K | |
| 87510 | <1% | 3,206 | $63K | |
| 99201 | <1% | 1,079 | $43K | |
| 87660 | <1% | 1,987 | $37K | |
| 86901 | <1% | 8,173 | $31K | |
| S4993 | Contraceptive pills for birth control | <1% | 436 | $29K |
| J2788 | Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.) | <1% | 582 | $22K |
| 85018 | <1% | 6,562 | $17K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 840 | $16K |
| 81513 | <1% | 224 | $11K | |
| 96127 | <1% | 1,686 | $11K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,832 | $11K |
| J3490 | Unclassified drugs | <1% | 558 | $10K |
| 11983 | <1% | 53 | $9K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 403 | $9K |
| 81002 | <1% | 1,985 | $5K | |
| 59200 | <1% | 38 | $3K | |
| 99000 | <1% | 11,907 | $3K | |
| 90739 | <1% | 12 | $1K | |
| 59841 | <1% | 12 | $867.90 | |
| 87529 | <1% | 26 | $648.88 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 422 | $636.73 |
| 87806 | <1% | 14 | $455.21 | |
| 99459 | <1% | 17 | $288.93 | |
| 87210 | <1% | 17 | $77.86 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJACKSON, FIONA (SR. DIRECTOR OF ENTERPRISE OPS)